Alice E. Petty
Sydney, NSW 2052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
TAAR1 Regulates Presynaptic Dopamine Function: Evidence From Preclinical Studies and a Phase 1b Trial in Patients With Schizophrenia.
Journal: Biological psychiatry
Published: May 08, 2025
The trace amine-associated receptor 1 regulates presynaptic dopamine function: evidence from preclinical studies and a phase 1b trial in patients with schizophrenia.
Journal: Biological psychiatry
Published: May 08, 2025
Transcriptional evidence of reduced BDNF trophic capacity in the post-mortem human midbrain of schizophrenia cases with high inflammation.
Journal: Translational psychiatry
Published: June 28, 2024
Correction: Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.
Journal: Molecular imaging and biology
Published: April 03, 2024
Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.
Journal: Molecular imaging and biology
Published: August 07, 2023
Increased levels of a pro-inflammatory IgG receptor in the midbrain of people with schizophrenia.
Journal: Journal of neuroinflammation
Published: March 11, 2022
Animal Models of Relevance to the Schizophrenia Prodrome.
Journal: Biological psychiatry global open science
Published: September 23, 2021
Enhanced Dopamine in Prodromal Schizophrenia (EDiPS): a new animal model of relevance to schizophrenia.
Journal: NPJ schizophrenia
Published: October 16, 2018
Vitamin D and the brain: Genomic and non-genomic actions.
Journal: Molecular and cellular endocrinology
Published: February 03, 2017
Transient Dysregulation of Dopamine Signaling in a Developing Drosophila Arousal Circuit Permanently Impairs Behavioral Responsiveness in Adults.
Journal: Frontiers in psychiatry
Published: December 01, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026